Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2010
06/10/2010US20100143309 Viral vectors
06/10/2010US20100143308 Akt nucleic acids, polypeptides, and uses thereof
06/10/2010US20100143304 Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
06/10/2010US20100143302 Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof
06/10/2010US20100143298 Colloidal metal compositions and methods
06/10/2010US20100143292 Il-21 variants
06/10/2010DE102008062285A1 Expression system, useful for expression of e.g. peptide, comprises nucleic acid sequences encoding a gene product to be expressed or a cloning site in which the nucleic acid sequences can be cloned and sequences encoding repressor protein
06/10/2010DE102006003777B4 Vorrichtung zur Verarbeitung von biologischen Proben und Verwendung einer Vakuumanschlusssäule oder eines Vakuumanschlussröhrchens An apparatus for processing of biological samples, and using a vacuum connection column or a vacuum connection tube
06/10/2010CA2776949A1 Methods and compositions for treating p.acnes
06/10/2010CA2748712A1 Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis
06/10/2010CA2746003A1 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
06/10/2010CA2746001A1 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
06/10/2010CA2745853A1 Farnesene synthase
06/10/2010CA2745838A1 Plant growth promoting protein complex
06/10/2010CA2745832A1 Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
06/10/2010CA2745811A1 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
06/10/2010CA2745781A1 Universal biological sample processing
06/10/2010CA2745760A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/10/2010CA2745746A1 Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer
06/10/2010CA2745603A1 Use of phenol soluble modulins for the development of vaccines
06/10/2010CA2745527A1 Leptin and leptin analog conjugates and uses thereof
06/10/2010CA2745524A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
06/10/2010CA2745499A1 Peptide therapeutic conjugates and uses thereof
06/10/2010CA2745473A1 Anti-cobra toxin antibody fragments and method of producing a vhh library
06/10/2010CA2745470A1 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
06/10/2010CA2745408A1 Wdrpuh epitope peptides and vaccines containing the same
06/10/2010CA2745329A1 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
06/10/2010CA2745271A1 Dual variable domain immunoglobulins and uses thereof
06/10/2010CA2745259A1 Novel method for generation of rna virus
06/10/2010CA2745111A1 Modulation of olfml-3 mediated angiogenesis
06/10/2010CA2745074A1 Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same
06/10/2010CA2745031A1 Genome editing in rats using zinc-finger nucleases
06/10/2010CA2744836A1 Barley and malt-derived beverages with low dms levels
06/10/2010CA2744750A1 Bovine viral diarrhea virus with a modified erns protein
06/10/2010CA2744093A1 Usirna complexes
06/10/2010CA2743707A1 Methods and compositions for enhanced yield by targeted expression of knotted1
06/10/2010CA2710264A1 Anti-nr10 antibody and use thereof
06/09/2010EP2194146A1 A molecular beacon and a method for its synthesis
06/09/2010EP2194145A1 Diagnosing and monitoring transplant rejection based on marker expression levels
06/09/2010EP2194139A1 Biochemical synthesis of 6 amino caproic acid
06/09/2010EP2194137A2 Cells comprising codon optimized retroviral particles
06/09/2010EP2194136A2 Nucleic acid sequences from yeast encoding proteins associated with abiotic stress response and transformed plant cells and plants with increased tolerance to environmental stress
06/09/2010EP2194135A2 Nucleic acid sequences from yeast encoding proteins associated with abiotic stress response and transformed plant cells and plants with increased tolerance to environmental stress
06/09/2010EP2194134A2 Nucleic acid sequences from yeast encoding proteins associated with abiotic stress response and transformed plant cells and plants with increased tolerance to environmental stress
06/09/2010EP2194133A2 Amylases, nucleic acids encoding them and methods for making and using them
06/09/2010EP2194132A1 Vaccine composition comprising a mixture of a recombinant protein containing a C-terminal p19 fragment of the MSP-1 protein from plasmodium falciparum and another recombinant p19 protein from a plasmodium homologous to P. falciparum
06/09/2010EP2194131A2 Cyclin-dependent kinase inhibitors and uses thereof
06/09/2010EP2194130A1 Cytokine ZCYTO18
06/09/2010EP2194129A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
06/09/2010EP2194128A1 Compositions and methods for inhibiting expression of the PCSK9 gene
06/09/2010EP2194127A1 Primate T-Lymphotropic viruses
06/09/2010EP2194126A1 Method of constructing cells with high productivity of foreign protein
06/09/2010EP2194125A2 New antibiotic-sensitive lactic acid bacteria strains
06/09/2010EP2194123A1 DNA polymerase fusions and uses thereof
06/09/2010EP2194122A1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells
06/09/2010EP2194120A1 Bioprocessing ligno-cellulose into ethanol with recombinant clostridium
06/09/2010EP2194116A1 Transfection device utilizing sericin
06/09/2010EP2194067A2 Antibodies to insulin-like growth factor I receptor (IGF-IR)
06/09/2010EP2194066A1 Modified antibody constant region
06/09/2010EP2194064A1 FGF-21 fusion proteins
06/09/2010EP2193831A1 Parallel extraction of different biomolecules made of Formalin-fixed tissue
06/09/2010EP2193807A1 Cyclosporin a-binding protein
06/09/2010EP2193804A2 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens
06/09/2010EP2193803A1 Nucleic acids encoding immunoglobins carrying gp100 and TRP2 epitopes
06/09/2010EP2193801A2 Caspase-8 and inflammation, infection and wound healing
06/09/2010EP2193204A2 Novel lipophilic compositions and uses thereof
06/09/2010EP2193203A1 Plants having increased yield-related traits and a method for making the same
06/09/2010EP2193202A2 Plants with increased yield
06/09/2010EP2193201A1 Plants with increased yield
06/09/2010EP2193200A1 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof
06/09/2010EP2193198A2 Amidohydrolases for preparing foodstuffs or stimulants
06/09/2010EP2193146A2 Rationally designed, synthetic antibody libraries and uses therefor
06/09/2010EP2193140A2 Compositions of asymmetric interfering rna and uses thereof
06/09/2010EP2192925A1 Targeting rna with external guide sequences
06/09/2010EP2192889A2 Cosmetic methods and compositions for repairing human skin
06/09/2010EP1804835B1 Multimeric constructs
06/09/2010EP1745148B1 A method for identifying activators of gene transcription
06/09/2010EP1721973B1 Mutant bacterium belonging to the genus bacillus
06/09/2010EP1685248B1 Oxidoreductase from metschnikowia zobellii
06/09/2010EP1641830B1 Emitter-binding peptides causing a change in the spectral emission properties of the emitter
06/09/2010EP1572744B1 Immunoglobulin variants and uses thereof
06/09/2010EP1459727B1 Nonhuman model animal unresponsive to immunopotentiating synthetic compound
06/09/2010EP1411117B1 NASBA based method for detecting mycobacterium tuberculosis
06/09/2010EP1385864B1 Anti-VEGF-2 antibodies
06/09/2010EP1377826B1 Opiate receptors
06/09/2010EP1335981B1 18480 human protein kinase molecules and uses therefor
06/09/2010EP1326988B1 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor
06/09/2010EP1062226B1 High affinity nucleic acid ligands of the complement system c5 protein
06/09/2010EP0863202B1 Recombinant sendai virus
06/09/2010CN1994465B CCR5 autogenous polypeptide vaccine and preparation method thereof
06/09/2010CN1993470B Generation of plants with altered oil content
06/09/2010CN1986568B INF-alpha expression relevant protein and its coding gene
06/09/2010CN1982324B Oncogene, recombinant protein derived therefrom, and uses thereof
06/09/2010CN1981043B Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
06/09/2010CN1974759B Attenuated salmonella transporting recombinant plasmid and its application in treating tumor
06/09/2010CN1922325B Gene expression technique
06/09/2010CN1922324B Bacterial virulence factors and uses thereof
06/09/2010CN1919867B Soybean Trihelix transcription factor, encode gene and application thereof
06/09/2010CN1919866B Soybean Trihelix transcription factor, encode gene and application thereof
06/09/2010CN1914319B Method for chromatographic separation of a nucleic acid mixture
1 ... 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 ... 4023